DIP
ANIP icon

DT Investment Partners’s ANI Pharmaceuticals ANIP Stock Holding History

DT Investment Partners’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,280
Closed -$51.5K – 472
2022
Q4 		$51.5K Buy
+1,280
New +$48.1K 0.01% 199

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

DT Investment Partners's ANIP Position: Q1 2023 in Review

DT Investment Partners sold out of ANI Pharmaceuticals (ANIP) in Q1 2023, closing a stake of 1,280 shares — an estimated $51.5K sold.

DT Investment Partners first reported a position in ANIP in Q4 2022 and held it in 1 quarter. The position peaked at $51.5K in Q4 2022. 138 funds tracked by Wall St. Rank hold ANIP as of Q1 2023.

  • DT Investment Partners reported no remaining ANI Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • DT Investment Partners sold 1,280 ANI Pharmaceuticals shares in Q1 2023, an estimated $51.5K.
  • DT Investment Partners first reported a position in ANI Pharmaceuticals in Q4 2022 and held it in 1 quarter.
  • DT Investment Partners's ANI Pharmaceuticals position peaked at $51.5K in Q4 2022.
  • 138 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2023.

Based on DT Investment Partners's 13F filing for Q1 2023, filed 3 May 2023.